XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2021   65,109,000      
Balance at beginning of period at Dec. 31, 2021 $ 164,391 $ 6 $ 552,083 $ 0 $ (387,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 410,000 410,000      
Issuance of common stock upon exercise of stock options $ 955   955    
Issuance of common stock upon release of stock awards (in shares)   373,000      
Stock-based compensation 14,531   14,531    
Taxes paid related to net share settlement of equity awards (in shares)   (81,000)      
Taxes paid related to net share settlement of equity awards (1,488)   (1,488)    
Net Loss (33,592)       (33,592)
Balance at end of period (in shares) at Dec. 31, 2022   65,811,000      
Balance at end of period at Dec. 31, 2022 $ 144,797 $ 6 566,081 0 (421,290)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 283,000 283,000      
Issuance of common stock upon exercise of stock options $ 559   559    
Issuance of common stock upon release of stock awards (in shares)   796,000      
Issuance of common stock in connection with an equity sales agreement, net of issuance costs (in shares) 3,079,421 3,080,000      
Issuance of common stock in connection with an equity sales agreement, net of issuance costs $ 7,932 $ 1 7,931    
Stock-based compensation 9,971   9,971    
Taxes paid related to net share settlement of equity awards (in shares)   (65,000)      
Taxes paid related to net share settlement of equity awards (404)   (404)    
Net Loss (76,240)       (76,240)
Balance at end of period (in shares) at Dec. 31, 2023   69,905,000      
Balance at end of period at Dec. 31, 2023 $ 86,615 $ 7 584,138 0 (497,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 399,000 399,000      
Issuance of common stock upon exercise of stock options $ 1,291   1,291    
Issuance of common stock upon release of stock awards (in shares)   842,000      
Issuance of common stock warrants in connection with debt issuance 859   859    
Issuance of common stock under employee stock purchase plan (in shares)   264,000      
Issuance of common stock under employee stock purchase plan $ 563   563    
Issuance of common stock in connection with an equity sales agreement, net of issuance costs (in shares) 0 10,440,000      
Issuance of common stock in connection with an equity sales agreement, net of issuance costs $ 29,736 $ 1 29,735    
Stock-based compensation 13,087   13,087    
Net Loss (65,276)       (65,276)
Other comprehensive loss 52     52  
Balance at end of period (in shares) at Dec. 31, 2024   81,850,000      
Balance at end of period at Dec. 31, 2024 $ 66,927 $ 8 $ 629,673 $ 52 $ (562,806)